In line with beneficial effects of higher αKlotho availability, PKC activity is a driver of kidney disease, in particular of diabetic nephropathy, which is among the leading causes for declining kidney function ultimately resulting in end-stage renal disease [48]. This evidence concerns the gene PRRT2 and chronic kidney disease.